Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19

NCT04635943 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Coronavirus Infection
SARS-CoV Infection

Interventions

DRUG: Ivermectin
DRUG: Placebo

Sponsor

Universidad Peruana Cayetano Heredia

Collaborators

[object Object]